Attendees must be registered for the American Academy of Optometry 2025 Conference in order to attend this program
Wednesday, October 8, 2025
5:30 PM – 6:30 PM
Boston Convention & Exhibition Center
415 Summer St
Boston, MA 02210
Meeting Room: Level 2, Room: 206AB
PROGRAM FEATURES
- Downloadable animations, education, and practice aids
- 1.0 CE Credit
PRESENTING FACULTY
 |
Cecelia Koetting, OD, FAAO, DipABO Assistant Professor University of Colorado School of Medicine Denver, Colorado |
 |
Walter Whitley, OD, MBA, FAAO Director of Professional Relations and Education Virginia Eye Consultants Regional Medical Director – Mid-Atlantic EyeCare Partners, LLC Norfolk, Virginia |
PROGRAM OVERVIEW
This educational activity is designed to enhance medical professionals’ expertise in managing Demodex blepharitis by improving their ability to apply best practices for its early detection and accurate differentiation from other ocular conditions to ensure timely diagnosis. It will enable participants to assess the latest clinical evidence on novel therapeutics and their impact on patient outcomes, and equip them to integrate emerging agents into individualized management strategies.
TARGET AUDIENCE
This activity is intended to meet the educational needs of optometrists, ophthalmologists, and optometry technicians involved in the diagnosis and management of patients with Demodex blepharitis.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
- Explain best practices for early detection and differentiation of Demodex blepharitis from other ocular conditions to ensure timely and accurate diagnosis
- Evaluate the latest clinical data on novel therapeutics for Demodex blepharitis and their role in improving patient outcomes
- Implement new and emerging agents into individualized treatment paradigms for patients with Demodex blepharitis based on the most up-to-date clinical evidence
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
COPE CREDIT DESIGNATION
Med Learning Group designates this asynchronous activity for a maximum of 1.0 COPE credit hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]
